Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Neuropsychology. 2009 Sep;23(5):551–562. doi: 10.1037/a0016277

Table 5.

Mean effect sizes for neuropsychological measures in patients with bipolar illness during a manic/mixed phase as compared to healthy controls. Measures are organized by neurocognitive domain.

Measure k N
(patient/control)
d 95% CI Z p Qw p Nfs
Attention
CPT 4 107/103 .79 .50/1.06 5.49 <.0001 .06 >.99 12
Trails A 4 111/117 .90 .62/1.18 6.40 <.0001 .71 .87 14
Verbal
Memory
R/CVLT
Total
6 140/157 1.43 1.17/1.68 11.09 <.0001 8.188 .15 37
R/CVLT
Long Delay
Recall
4 91/128 1.05 .76/1.35 7.02 <.0001 1.115 .77 17
Language
FAS 4 109/119 .51 .24/.77 3.70 .0002 2.78 .43 6
AN 4 100/113 .59 .31/.87 4.11 <.0001 2.69 .44 8
Executive-
Function
WCST-PE 4 98/123 .72 .45/1.00 5.10 <.0001 5.27 .15 10
Trails B 4 111/117 .64 .37/.91 4.62 <.0001 4.61 .20 9

Note: AN=Animal Naming, AVLT=Auditory Verbal Learning Test, CPT=Continuous Performance Test, CVLT=California Verbal Learning Test, DS=Digit Span, FAS=Controlled Oral Word Association Test, RAVLT=Rey Auditory Verbal Learning Test, WCST=Wisconsin Card Sorting Test, PE=Perseverative Errors. k, number of studies; N, number of participants; ES, weighted effect-size between-groups; 95% CI, 95% confidence interval; Z significance statistic between the groups, Qw within-group homogeneity statistic, Nfs, indicates the number of null findings that would need to be found to reduce the mean effect size to .20.